The HCPLive endocrinology page is a comprehensive resource for clinical news and insights on endocrine system conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for diabetes, hormonal disease, and more.
September 18th 2024
The FDA has approved the Eversense 365, the world’s first 1-year continuous glucose monitor, with US availability expected in late 2024.
September 7th 2024
HCPLive Endocrinology's flagship diabetes podcast, hosted by Diana Isaacs, PharmD, and Natalie Bellini, DNP
Patient Participation in the Electronic Health Record Process
As more practices and hospitals enter the digital age with Electronic Health Records (EHR) and other health information technology tools, a recent article points out that all those efforts are only half the battle.
How Should I Handle This Patient Who Leaks Urine?
September 26th 2014A 58 year old G2P2, married woman presents to your office for her annual well woman exam. Upon questioning, she tells you that for several months she's been having trouble with urinary leaking. "I just can't seem to get to the bathroom on time and I feel like I go more often than usual." She also has been urinating at least twice during the night. She denies urinary burning or dysuria
American Diabetes Association 74th Scientific Sessions
September 19th 2014The 74th Scientific Sessions of the American Diabetes Association (ADA) brought together more than 17,300 attendees from more than 121 countries. This year's program included 96 symposia, 50 oral abstract sessions, 10 interest group discussions, 18 meet-the-expert sessions, and 10 special lectures and addresses. Cardiology Review is covering 6 of the top sessions.
Insulin Pumps Show Benefits Beyond Convenience
Patients diagnosed with type 1 diabetes have long known the benefits of ease and convenience that comes with using an insulin pump instead of relying on multiple daily insulin injections to control their condition. A recent study has shown that using a pump is also associated with positive effects on long-term cardiovascular risk and mortality.
Delving Into Adherence With Multiple Sclerosis Therapies
September 16th 2014Adherence is defined as conforming to the recommendations made by the provider with respect to timing, dosage, and frequency of medication taking, and following these recommendations is important for patients with multiple sclerosis (MS) to fully benefit from disease-modifying therapies (DMTs).
Review Finds Little Evidence to Link Testosterone Therapy and Increased Cardiovascular Risk
Staff scientists at the US Food and Drug Administration (FDA) have concluded that there's no "convincing evidence" linking testosterone replacement therapy with adverse cardiovascular events.
Exposure to Endocrine-disrupting Chemicals Associated with Low Serum Testosterone
A new study showing significant negative correlation between phthalate absorption and testosterone levels adds considerably more weight and significant new details to a growing body of research.
Model Helps Predict Patient Risk for Major Type 1 Diabetes Complications
Patients diagnosed with type 1 diabetes are at higher risk for developing major health complications but up until now there had been no reliable way to determine which complications a patient might develop or how severe they might be.
Stage 2 Deadline Rapidly Approaching
The end of September will mark the deadline set for hospitals across the country to reach Stage 2 of the Meaningful Use program for the year and that means the clock is ticking for health care professionals around the country to meet the goals set for them.
VBLOCK Shows Success with Diabetes, Hypertension and Weight Loss
A 3-year study of a product meant to help patients dealing with a wide range of conditions including diabetes, hypertension, and weight loss showed positive results according to manufacturer EnteroMedics, Inc.